Tuesday, August 16, 2022

Wockhardt initiates phase-III clinical study of new antibiotic candidate

Wockhardt initiates phase-III clinical study of new antibiotic candidate The company has completed the first site initiation visit for the study, Wockhardt said in a statement.

from Moneycontrol Business News https://ift.tt/hkgn6N2

No comments:

Post a Comment

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...